TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX/MDNA

Medicenna Therapeutics Corp (MDNA : TSX)

Common Stock

$0.40

CAD

+0.01 (1.27%)

Last updated: 2026-08-11

Get MDNA alerts:

MDNA

Medicenna Therapeutics Corp

Source:WealthAwesomeWealthAwesome
$0.01 (2.56%)
30 day period
$0.34$0.37$0.40Jun 29Jul 21Aug 11

Performance

1 Day

+1.27%

1 Week

+11.11%

1 Month

+8.11%

YTD

-60.00%

Key Statistics

Market Cap

$36.92M

52W High

$1.97

52W Low

$0.34

P/E Ratio

-

50 Day MA

$0.39

200 Day MA

$0.80

Beta

1.89

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/11/2026$0.40$0.40$0.40$0.40$0.407,133
8/10/2026$0.39$0.40$0.38$0.40$0.4027,372
8/7/2026$0.39$0.39$0.38$0.38$0.3821,381
8/6/2026$0.40$0.40$0.38$0.39$0.3941,383
8/5/2026$0.38$0.40$0.36$0.38$0.3870,820
8/4/2026$0.36$0.37$0.34$0.36$0.3649,758
7/31/2026$0.34$0.36$0.34$0.36$0.3614,500
7/30/2026$0.35$0.35$0.34$0.35$0.3579,482
7/29/2026$0.36$0.36$0.34$0.35$0.3525,054
7/28/2026$0.35$0.35$0.35$0.35$0.3534,103

Analyst Price Targets

Based on analyst covering MDNA

📈

Wall Street analysts forecast MDNA stock price to rise 700.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$3.20

+700.0% Upside

Current Price

C$0.40

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MDNA's historical volatility

HistoricalForecast68%95%
C$0.20C$0.29C$0.39C$0.49C$0.58C$0.68TodayApr 2Jun 8Aug 11Sep 23Nov 6Dec 19

30-Day Vol

41.8%

Annualized

90-Day Vol

68.5%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.33

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.38C$0.33C$0.44
60 trading daysC$0.36C$0.29C$0.44
90 trading daysC$0.33C$0.26C$0.43

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Medicenna Therapeutics Corp

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-22.40M
Profit Margin
0.00%
ROE (TTM)
-170.64%
EPS (Diluted)
-0.22
Book Value
0.03

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MDNA

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
AABAberdeen International Inc.$0.03+50.00%
SSherritt International Corporation$0.26+27.50%
ACBAurora Cannabis Inc$5.03+24.81%
OGIOrganiGram Holdings Inc$1.69+18.18%
FRXFennec Pharmaceuticals Inc$17.63+15.38%
COPRCoppernico Metals Inc.$0.46+15.00%
STLRSTLLR Gold Inc.$1.77+14.94%
ORIOOrion Digital Corp.$1.12+12.00%

MDNA.TO news timeline

15 articles covering MDNA.TO, most recent first

Latest

Why Medicenna Therapeutics Corp stock fell yesterday

Stocks

Advertisement